DDS - 2007 (School of Dentistry of Araçatuba, São Paulo State University), Specialist in Pediatric Dentistry - 2010 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Syndromes and Craniofacial Anomalies - 2013 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), MSc in Orofacial Clefts and Related Anomalies - 2014 (Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo), Specialist in Health Management - 2016 (Federal University of São Paulo), PhD in Experimental Pathology (in degree) – Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.

Cleft lip and palate, Pediatric dentistry, Pediatrics, Pathology, Public health Pediatric dentistry Cleft lip and palate Pathology Public health

Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Professor, Dept for Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia

Medicine

Dr. Uqbah Iqbal is a Socioeconomic Researcher at Research for Social Advancement. Winning Second Place in Malaysian Historical Essay Writing Competition 2013, he was the recipient of Research University Fellowship Scheme, Graduate on Time Award and Outstanding Student Award from Faculty of Social Sciences and Humanities as well as the Youngest Ph.D. in History Holder

Management and Administrative Sciences Review, Social and Basic Sciences Research Review

Sinéad Furey graduated from Ulster University (Northern Ireland) with a research degree (DPhil), with specialties including food and consumer policy and legislation. She started working at the Consumer Council where she continued her research as a Senior Consumer Affairs Officer in food, water and consumer policy; as a Nutritional Associate at the Education and Training Inspectorate inspecting approaches to whole-school food policies and practices and as a senior Executive Officer at the Food Standards Agency where she led food policy research programmes. She currently lectures and researches at Ulster University with research interests in food poverty and food access.

Health Economics

Farid Shirazi, B.Eng., MSc. CS, Ph.D. is a Senior Researcher at Institute for Innovation and Technology Management at Ryerson University, Toronto, Canada and an Assistant Professor and Faculty Learning Edge Advisor of Ted Rogers school of Information Technology Management. Dr. Shirazi's research focuses mainly on the impact of ICTs on the social and economic development. His main research interests are IT-enabled sustainability and development, Cloud Computing, E-government strategies, Green IS management as well as the ethical and security perspectives associated with the introduction and use of ICTs.

Health Economics

Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer. In the past, she worked at both global and regional HEOR functions at AstraZeneca and BiogenIdec being based in Sweden and Switzerland respectively. At Bristol Myers Squibb and Lunbeck she was leading Market Access teams in CEE and Nordic Region. Her practical skills in the field of health economics were developed during six years employment contract at the Kalmar County Council in Sweden. Since 2015, she has been working with pricing &reimbursement challenges in the field of medical devices. Currently being Global Market Access Principal Consultant for Straub Medical. Before that, Katarzyna was a Senior HEOR Director at GE Healthcare.

Health Economics

Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees.Asche’s research is funded by a variety of state/federal agencies and health system providers.

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

Dr. Elder has 40 years of service within the pharmaceutical industry, with Sterling, Syntex and for the last 23 years with GSK. He is now an independent CMC consultant and has broad based experience in impurities and their control and analytical method development. Dr. Elder obtained his PhD in crystallography from the University of Edinburgh. Dr. Elder is a visiting professor at King’s College, London. He is a member of the British Pharmacopoeia. He is the immediate past chairman of JPAG (Joint Pharmaceutical Analysis Group). He is a member of the Editorial Advisory Board for the Journal of Pharmaceutical Sciences. He has published over 100 papers in international journals and has given 13 webinars and over 115 presentations at international symposia. He has co-edited a book on the Analytical Characterisation and Separation of Oligonucleotides and their Impurities (with George Okafo and Mike Webb) and a second on the ICH Quality Guidelines (with Andy Teasdale and Ray Nims).

Ailawadhi has expertise in the field of plasma cell disorders, specifically multiple myeloma and focuses on clinical drug development as well as a special interest in secondary data analysis looking at outcome disparities and healthcare economics. He has accumulated vast experience in the area of disparities in healthcare utilization and outcomes by patient race and ethnicity and how the management, access and effects of therapeutic interventions may be different for various patient subgroups. Several of his research projects focusing on healthcare economics, cost-effectiveness and outcome disparities have been recognized in the form of presentations at national and international meetings as well as peer-reviewed publications.

Konstantinos Papadopoulos is a physiotherapist.He holds an Msc degree in exerscise rehabilitation and a PhD degree in health care science with expertise in patellofemoral pain syndrome.

Suraj Singh Senjam currently working as faculty in community opthamology department. he has passed his MBBS from Regional Institute Of Medical Sciences.

Sarah Neville is the Director, Pricing at the Independent Hospital Pricing Authority (IHPA), and is responsible for delivering the National Efficient Price annually. Sarah’s background is in mathematics and statistics, holding a Ph.D. in statistics from the University of Wollongong. She was invited to present doctoral research at the University of Oxford in 2012. Sarah recently spent six weeks in remote Australia working with Miwatj Health Aboriginal Corporation developing better ways to communicate key health statistics to Indigenous Australians.

Dr. Ailawadhi has expertise in the field of plasma cell disorders, specifically multiple myeloma and focuses on clinical drug development as well as a special interest in secondary data analysis looking at outcome disparities and healthcare economics. He has accumulated vast experience in the area of disparities in healthcare utilization and outcomes by patient race and ethnicity and how the management, access and effects of therapeutic interventions may be different for various patient subgroups. Several of his research projects focusing on healthcare economics, cost-effectiveness and outcome disparities have been recognized in the form of presentations at national and international meetings as well as peer-reviewed publications.

Samath D. Dharmaratne is an Associate Professor and a Consultant Community Physician attached to the Department of Community Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka and has been in the permanent academic cadre for the past 22 years. Samath was a former Head of the Department, a former Public Health specialist in the World Bank, and a former postgraduate fellow in the University of Washington. He is a Senior Fellow of the Postgraduate Institute of Medicine, University of Colombo. He is a Board Director of the Consortium of Universities for Global Health and the Course Coordinator of the Diploma in Exercise and Sport Sciences, Faculty of Medicine.

Richeal M. Burns is a health economist specializing in economic evaluation alongside clinical trials and burden of illness studies. Richeal has been involved in a range of disease areas including Prostate Cancer, Blood Disorders, Inflammatory Bowel Disease, Childhood Behaviors and Cardiovascular Disease. Her interests include examining methodological concerns in measuring quality of life and the application of quality of life measurement in economic evaluation

Arun Kumar Aggarwal is MD in Community Medicine and postgraduate in Health & Hospital Administration. He is Professor in School of Public Health of premier tertiary care institute (PGIMER) at Chandigarh, North India. He has done WHO fellowship in Health Financing & Economics from Bangkok and World Bank online course on Basics of Health Economics.

Sushil Ranjan Howlader was Professor and Director of the Department of Economics of University of Dhaka from 1995 1998 and thereafter became professor of the institute of health Economics of University of Dhaka, Dhaka. He was the founder Director of the Institute of Health Economics of University of Dhaka and worked as Director from 1998 to 2005 and again from 2007 to 2010 (July). He is also the former Director of the Bureau of Economic Research, University of Dhaka.He has carried out his doctoral study as a Winrock scholar on Development Economics at Jawaharlal Nehru University, New Delhi, in 1993.

Rafia Rahman works as Assistant Professor, Lecturer at Institute of Health Economics, University of Dhaka. She works with national and international NGOs for around nine years then an academician. Her wishes to increase, ensure health care services by registered trained provider in the countries. Rafia also has work experiences like, Training on “Norplant”, conducted by Mohammadpur Fertility Services & Training Center, Training on “No-Scalpel Vasectomy (NSV)” conducted by AITEM, Dhaka, Completed “Continuous Technology Update (CTU)” workshop organized by NSDP, Attended a training on “Integrated Management on Childhood Illness (IMCI)” at Dhaka Shishu Hospital, Attended a training on “Follow-up after IMCI Training”– at Ad din Hospital organized by NSDP, Completed “RTI/STI Management training” organized by NSDP, conducted by Radda MCH, “Quality Monitoring & Supervision of TB Program” workshop organized by URC, Supervision and performance evaluation of medical staff, Maintain liaison between the hospital and providing training to relevant medical and Skilled Birth Attendants (SBA), Developed an on-going training program for nursing and clinical staff, Provide Active Management of Third Stage of Labor (AMTSL) in four (04) districts of Bangladesh. She Attended 9th south East Asia Regional Scientific Meeting,” Epidemiology: A key to Achieve the Millennium development Goals” Workshop.

Professor Khalid’s is a clinical cardiologist by training, Professor Khalid previously served as the Dean of Universiti Teknologi MARA’s Faculty of Medicine. Under his stewardship, the faculty recorded tremendous growth and established itself as one of the foremost medical faculties in the nation. Prior to that, Professor Khalid played a number of key roles – including serving as Dean – in a career spanning two decades at Universiti Kebangsaan Malaysia. He also served as a consultant cardiologist at both universities where he was instrumental in developing the Heart Centres at these universities. Professor Khalid began his medical career as a student at The University of Melbourne, Australia. He was then trained in Cardiology at the University of Newcastle-upon-Tyne, UK. On returning to Malaysia, he built a strong career in academia, bolstered by national and international recognition of his contributions. He is a firm advocate of research and development and his findings are frequently published in high-impact international journals. His papers are cited and referred to by many of his peers, adding credence to his standing as an academic. What Professor Khalid brings to UCSI further enhances the University’s strong links with the industry and its vibrant student life. The latest addition to Professor Khalid’s ever expanding list of accolades and awards is a Doctor of Medical Sciences (honoris causa) conferred by his alma mater, The University of Melbourne, Australia in October 2014. The citation for the honorary doctorate by the Melbourne University’s Council identifies him as a person of distinguished eminence in medical science, research and effective medical education. His international outlook was best demonstrated in his development and forging of strategic partnerships between UCSI and world leading universities, culminating in UCSI’s proudest moment when our top Year 2 medical student was selected for an intercalated research year at Harvard University in the USA.

Dr. Teckle is a Health Economist at the Canadian Centre for Applied Research in Cancer Control (ARCC), British Columbia Cancer Agency and an Assistant Professor in the School of Population and Public Health at the University of British Columbia. Previously he held positions at Health Economics Research Unit, University of Aberdeen UK. Whilst at the University of Aberdeen, Dr. Teckle was part of a research team that was commissioned by the Scottish Executive Health Department in 2005 to improve and refine the Arbuthnott Resources Allocation Formula used in Scotland. Since he joined the ARCC in 2006, Dr. Teckle has been working as a co-investigator in three projects: “Health-related quality of life in cancer patients”; “Long-term income and employment outcomes in cancer-survivors”, and “Phase-specific and lifetime costs of cancer in British Columbia and Ontario”. The objective of the first project is to evaluate the reliability and validity of cancer-specific measures of health related-quality of life in patients with cancer in BC. The objective of the second project is to estimate the effect of socio-demographic and clinical factors on cancer survivors’ income, and their ability to participate in the labor force using cross-sectional and longitudinal models; and the objective of the last project is to estimate costs for eighteen most common types of cancer in British Columbia. Over the course of his academic career, Dr. Teckle has published a number of scientific papers.

Katarzyna is a Market Access Director for Region East at Lundbeck. In the past, she worked for AstraZeneca, Bristol Myers Squibb as well as BiogenIdec leading Market Access teams in CEE Region. In total, she has been working for pharmaceutical industry for more than ten years now. The last six years she devoted mainly to Market Access for CEE Region. Her office is located in Finland. In the past she was based in Sweden and Switzerland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa has been invited to review manuscripts for Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union\'s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes.

Carl Asche is the Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria, where he is a Research Professor both in the Departments of Medicine (Peoria) and Pharmacy Systems, Outcomes & Policy (Chicago). He is also a research affiliate with the University of Victoria Centre on Aging. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of being the author or co-author of over 75 papers appearing in the medical and economic literature. He is the editor of the forthcoming book entitled, “Applying Comparative Effectiveness Data to Medical Decision Making: A Practical Guide” (Adis, 2015). He has presented his research at seminars and conferences both nationally and internationally. He has served on numerous national and international health economics focused editorial, grant review, advisory boards and committees.Asche’s research is funded by a variety of state/federal agencies and health system providers.